Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Europe/epidemiology; Female; Great Britain/epidemiology; Homes for the Aged; Humans; Hydroxycholecalciferols/blood/deficiency; Osteoporosis, Postmenopausal/blood; Prevalence; Radioimmunoassay; Sunlight; Vitamin D Deficiency/blood/epidemiology
Abstract :
[en] The reduced capacity of older skin to synthesize vitamin D(3) under the influence of ultraviolet light makes older persons at risk of vitamin D deficiency. The risk could even be increased in institutionalized persons owing to their lower sunshine exposure. It has been reported that an inadequate vitamin D level is associated with secondary hyperparathyroidism, increased bone turnover, and bone loss, which increase fracture risk. The objective of this study was to assess the prevalence of inadequate serum vitamin D levels in institutionalized, postmenopausal, osteoporotic women. Assessment of 25-hydroxyvitamin D [25(OH)D] was performed in 445 institutionalized, osteoporotic women from nine countries (Australia, Belgium, France, Germany, Hungary, Italy, Poland, Spain and UK). For each institutionalized woman, three age-matched, noninstitutionalized, osteoporotic controls were also included. Four cutoffs of 25(OH)D inadequacy were fixed: less than 80, less than 75, less than 50 and less than 30 nmol/l. Mean age was 79.7 years (standard deviation [SD] = 5.8) for the institutionalized women and 79.5 years (SD = 5.5) for the noninstitutionalized women (p = 0.45). Significantly fewer institutionalized women received vitamin D supplements (13.2 vs 24.0%; p < 0.0001). In women without vitamin D supplements, the level of 25(OH)D was significantly lower in institutionalized women (56.9 [SD = 23.9] nmol/l) compared with noninstitutionalized women (63.2 [SD = 22.0] nmol/l; p < 0.0001). In institutionalized women (without vitamin D supplements), the prevalence of 25(OH)D inadequacy was 10.4, 41.2, 80.3 and 84.2% when considering cutoffs of 80, 75, 50 and 30 nmol/l, respectively. In the control group, the prevalence was 2.7, 22.9, 74.4 and 81.7%, respectively. The prevalence of vitamin D inadequacy was significantly higher in institutionalized women when considering the 75, 50 and 30 nmol/l cutoffs but not when considering the 80 nmol/l cutoff. This study highlights a high prevalence of vitamin D inadequacy in institutionalized, osteoporotic women. Compared with age-matched osteoporotic controls, the prevalence of severe vitamin D inadequacy was substantially more important in institutionalized women. We believe that a greater awareness of the importance of vitamin D inadequacy is needed in order to address this public health problem.
Disciplines :
General & internal medicine
Author, co-author :
Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique - Département des sciences de la santé publique
Decock, Caroline
Delhez, Melanie
Collette, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control study.
Bischoff-Ferrari HA, Dietrich T, Orav EJ et al.: Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am. J. Clin. Nutr. 80(3), 752-758 (2004).
Bischoff HA, Stahelin HB, Dick W et al.: Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J. Bone Miner. Res. 18(2), 343-351 (2003).
Flicker L, Mead K, MacInnis RJ et al.: Serum vitamin D and falls in older women in residential care in Australia. J. Am. Geriatr. Soc. 51(11), 1533-1538 (2003).
Boonen S, Body JJ, Boutsen Y et al.: Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos. Int. 16(3), 239-254 (2005).
Compston J: Guidelines for the management of osteoporosis: the present and the future. Osteoporos. Int. 16(10), 1173-1176 (2005).
Kanis JA, Burlet N, Cooper C et al.: European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 19(4), 399-428 (2008).
Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY: The role of calcium and vitamin D in the management of osteoporosis. Bone 42(2), 246-249 (2008).
Barragry JM, France MW, Corless D et al.: Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin. Sci. Mol. Med. 55(2), 213-220 (1978).
Reginster JY: The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr. Med. Res. Opin. 21(4), 579-586 (2005).
Hollis BW: Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135(2), 317-322 (2005).
Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS: Vitamin D inadequacy among post-menopausal women: a systematic review. QJM 98(9), 667-676 (2005).
Fonad E, Wahlin TB, Winblad B, Emami A, Sandmark H: Falls and fall risk among nursing home residents. J. Clin. Nurs. 17(1), 126-134 (2008).
Tinetti ME, Williams CS: Falls, injuries due to falls, and the risk of admission to a nursing home. N. Engl. J. Med. 337(18), 1279-1284 (1997).
Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P: Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J. Clin. Endocrinol. Metab. 91(8), 2980-2985 (2006).
Heaney RP: Vitamin D: how much do we need, and how much is too much? Osteoporos. Int. 11(7), 553-555 (2000).
Heaney RP, Dowell MS, Hale CA, Bendich A: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J. Am. Coll. Nutr. 22(2), 142-146 (2003).
Drinka PJ, Goodwin JS: Prevalence and consequences of vitamin deficiency in the nursing home: a critical review. J. Am. Geriatr. Soc. 39(10), 1008-1017 (1991).
Komar L, Nieves J, Cosman F, Rubin A, Shen V, Lindsay R: Calcium homeostasis of an elderly population upon admission to a nursing home. J. Am. Geriatr. Soc. 41(10), 1057-1064 (1993).
Przybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N: Rapid correction of low vitamin D status in nursing home residents. Osteoporos. Int. 19(11), 1621-1628 (2008).
Drinka PJ, Krause PF, Nest LJ, Goodman BM: Determinants of vitamin D levels in nursing home residents. J. Am. Med. Dir. Assoc. 8(2), 76-79 (2007).
Reginster JY, Deroisy R, Pirenne H et al.: High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: a plausible role of increased parathyroid hormone secretion. Osteoporos. Int. 9(2), 121-128 (1999).
Reginster JY, Frederick I, Deroisy R et al.: Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly women. Osteoporos. Int. 8(4), 390-392 (1998).
Labossiere R, Bernard MA: Nutritional considerations in institutionalized elders. Curr. Opin. Clin. Nutr. Metab. Care 11(1), 1-6 (2008).
Bruyere O, Malaise O, Neuprez A, Collette J, Reginster JY: Prevalence of vitamin D inadequacy in European postmenopausal women. Curr. Med. Res. Opin. 23(8), 1939-1944 (2007).
Neuprez A, Bruyere O, Collette J, Reginster JY: Vitamin D inadequacy in Belgian postmenopausal osteoporotic women. BMC Public Health 7, 64 (2007).
Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P: Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos. Int. 19(5), 663-671 (2008).
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al.: Effect of vitamin D on falls: a meta-ana lysis. JAMA 291(16), 1999-2006 (2004).
Grant AM, Avenell A, Campbell MK et al.: Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365(9471), 1621-1628 (2005).
Porthouse J, Cockayne S, King C et al.: Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330(7498), 1003 (2005).
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B: Fracture prevention with vitamin D supplementation: a meta-ana lysis of randomized controlled trials. JAMA 293(18), 2257-2264 (2005).
Jackson RD, LaCroix AZ, Gass M et al.: Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 354(7), 669-683 (2006).
Law M, Withers H, Morris J, Anderson F: Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 35(5), 482-486 (2006).
Bischoff-Ferrari HA, Dawson-Hughes B: Where do we stand on vitamin D? Bone (2007).
Vieth R, Bischoff-Ferrari H, Boucher BJ et al.: The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 85(3), 649-650 (2007).
Adami S, Giannini S, Bianchi G et al.: Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos. Int. (2008)
Deane A, Constancio L, Fogelman I, Hampson G: The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis. BMC Musculoskelet. Disord. 8, 3 (2007).
Geller JL, Hu B, Reed S, Mirocha J, Adams JS: Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients. Endocr. Pract. 14(3), 293-297 (2008).
Suominen MH, Hosia-Randell HM, Muurinen S et al.: Vitamin D and calcium supplementation among aged residents in nursing homes. J. Nutr. Health Aging 11(5), 433-437 (2007).
